🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate how much of the LY2801653 drug is ...
Status
Completed
Location
Covance
Start Date
2015-02
Trial ID
NCT02370485
Treatments Being Tested
The main purpose of this study is to evaluate tolerability of merestinib mo...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2017-02-03
Trial ID
NCT03027284
Treatments Being Tested
The main purpose of this study is to evaluate the safety of ramucirumab in ...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2016-10-21
Trial ID
NCT02745769
Treatments Being Tested
Part A- The purpose of this study is to determine a safe dose of LY2801653 ...
Status
Completed
Location
Arizona Cancer Center
Start Date
2009-09-09
Trial ID
NCT01285037
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of ra...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center
Start Date
2016-05-19
Trial ID
NCT02711553
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Tennessee Oncology PLLC
Start Date
2016-06-29
Trial ID
NCT02791334
Treatments Being Tested
The purpose of this study is to evaluate the effect of food on merestinib (...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2016-05
Trial ID
NCT02779738
Treatments Being Tested
This research study is examining merestinib (a targeted therapy) as a possi...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2016-11-11
Trial ID
NCT02920996
Treatments Being Tested
This is an open label, pharmacodynamics, intrapatient dose escalation phase...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2018-01-11
Trial ID
NCT03292536
Treatments Being Tested
This research study is studying a combination of two targeted therapies as ...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2017-08-10
Trial ID
NCT03125239
Treatments Being Tested